IMMU
Immunomedics Inc
IMMU
IMMU
Delisted
IMMU was delisted on the 22nd of October, 2020.
192 hedge funds and large institutions have $3.48B invested in Immunomedics Inc in 2018 Q2 according to their latest regulatory filings, with 44 funds opening new positions, 79 increasing their positions, 51 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
192
Holders Change
+24
Holders Change %
+14.29%
% of All Funds
4.4%
Holding in Top 10
9
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+12.5%
% of All Funds
0.21%
New
44
Increased
79
Reduced
51
Closed
19
Calls
$118M
Puts
$184M
Net Calls
-$65.4M
Net Calls Change
-$72.2M
Top Buyers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$133M |
| 2 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$73.8M |
| 3 |
BlackRock
New York
|
+$52M |
| 4 |
Alkeon Capital Management
New York
|
+$43.8M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$42.4M |
Top Sellers
| 1 |
NMC
NEA Management Company
Timonium,
Maryland
|
-$40.5M |
| 2 |
ACP
Acuta Capital Partners
Redwood City,
California
|
-$26M |
| 3 |
State Street
Boston,
Massachusetts
|
-$23.6M |
| 4 |
O
OrbiMed
New York
|
-$18.1M |
| 5 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
-$15.1M |
